The InstaDetect Platform, developed by Neuome Technologies Pvt. Ltd., represents the pinnacle of diagnostic innovation. As a niche biotech startup, Neuome is renowned for its proprietary technologies and assays, which have extensive applications in the molecular diagnostics landscape.

Committed to sustainability and excellence, Neuome specializes in developing therapeutic, prophylactic, and diagnostic platforms that address critical challenges in healthcare. Through our focused research and development, we have created advanced diagnostic solutions tailored to meet diverse needs in the biotech and life sciences sectors.

At the core of Neuome Technologies' innovation is the groundbreaking Xomics-N Platform. This state-of-the-art platform exemplifies the integration of multiple interdisciplinary fields, seamlessly combining bioinformatics, proteomics, nanotechnology, electronics, IT, and IoT. The result is a transformative molecular diagnostics tool that redefines precision and efficiency. Xomics-N employs advanced bioinformatics methodologies for lead identification and validation, embodying Neuome’s commitment to holistic scientific integration. By leveraging the power of diverse scientific disciplines, Neuome continues to set new benchmarks in the biotech industry, driving innovation and delivering next-generation solutions for molecular diagnostics.